Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
International Journal of Hematology, 05/08/2012
Ye H et al. – The study demonstrated that an elevated lipopolysaccharide–binding protein (LBP) level of >15000ng/ml may serve as a biomarker for the prediction and monitoring of Acute graft–versus–host disease (aGVHD).



